These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12523700)

  • 1. Foot and mouth disease: the future of vaccine banks.
    Forman AJ; Garland AJ
    Rev Sci Tech; 2002 Dec; 21(3):601-12. PubMed ID: 12523700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of antigen and vaccine banks in case of emergency vaccination in the European community.
    Füssel AE
    Dev Biol (Basel); 2004; 119():307-15. PubMed ID: 15742642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A global virtual network for foot-and-mouth disease in case of emergency.
    Palma EL
    Dev Biol (Basel); 2004; 119():317-31. PubMed ID: 15742643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination.
    Lombard M; Füssel AE
    Rev Sci Tech; 2007 Apr; 26(1):117-34. PubMed ID: 17633297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foot-and-mouth disease. Report urges U.K. to vaccinate herds.
    Stone R
    Science; 2002 Jul; 297(5580):319-21. PubMed ID: 12130760
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies I: Benefits of Higher Potency Vaccines and Associated NSP DIVA Test Systems in Post-Outbreak Surveillance.
    Barnett PV; Geale DW; Clarke G; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):367-87. PubMed ID: 24112127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of FMD virus.
    Donaldson AI
    Vet Rec; 2006 Apr; 158(16):571-2. PubMed ID: 16632535
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effectiveness of vaccination to prevent foot and mouth disease in several species].
    Orsel K
    Tijdschr Diergeneeskd; 2008 Jan; 133(1):14-6. PubMed ID: 18260556
    [No Abstract]   [Full Text] [Related]  

  • 10. Foot-and-mouth disease vaccines.
    Diaz-San Segundo F; Medina GN; Stenfeldt C; Arzt J; de Los Santos T
    Vet Microbiol; 2017 Jul; 206():102-112. PubMed ID: 28040311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Point of view of KNMvD concerning foot and mouth disease marker vaccine].
    van Leeuwen JM
    Tijdschr Diergeneeskd; 2001 Sep; 126(17):585. PubMed ID: 11596520
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
    Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in foot-and-mouth disease virus strain selection as an input to attain broad vaccine intraserotype cross-protection.
    Bergmann IE; Malirat V; Pedemonte A; Maradei E
    Expert Rev Vaccines; 2021 Jan; 20(1):13-22. PubMed ID: 33455492
    [No Abstract]   [Full Text] [Related]  

  • 14. Triggers for foot and mouth disease vaccination in the United States.
    Parent KB; Miller GY; Hullinger PJ
    Rev Sci Tech; 2011 Dec; 30(3):789-96. PubMed ID: 22435191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for controlling FMD.
    Vet Rec; 2006 Mar; 158(12):387. PubMed ID: 16565329
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolving perception on the benefits of vaccination as a foot and mouth disease control policy: contributions of South America.
    Bergmann IE; Malirat V; Falczuk AJ
    Expert Rev Vaccines; 2005 Dec; 4(6):903-13. PubMed ID: 16372885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current state of vaccines used in the field for foot and mouth disease virus in China.
    Li Z; Liu J
    Expert Rev Vaccines; 2011 Jan; 10(1):13-5. PubMed ID: 21162615
    [No Abstract]   [Full Text] [Related]  

  • 18. Extending the foot-and-mouth disease module to the control of other diseases.
    De Clercq K; Goris N
    Dev Biol (Basel); 2004; 119():333-40. PubMed ID: 15742644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need for improved vaccines against foot-and-mouth disease.
    de Los Santos T; Diaz-San Segundo F; Rodriguez LL
    Curr Opin Virol; 2018 Apr; 29():16-25. PubMed ID: 29544088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosecurity and FMD transmission.
    Dekker A
    Vet Rec; 2011 Feb; 168(5):126-7. PubMed ID: 21493485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.